Prudoxin Cream
NDC Package 0378-8130-45
Package Information
Prudoxin (doxepin hydrochloride) cream is a medication used to relieve itching from certain skin conditions (e.g., atopic dermatitis, eczema, neurodermatitis). This formulation utilizes a cream delivery system. Marketed by Mylan Pharmaceuticals Inc., this product is identified by NDC 0378-8130 and is authorized under FDA application NDA020126.
Identification & Billing
- RxCUI: 1000091 - doxepin HCl 5 % Topical Cream
- RxCUI: 1000091 - doxepin hydrochloride 50 MG/ML Topical Cream
- RxCUI: 1000091 - doxepin hydrochloride 5 % Topical Cream
- RxCUI: 1000093 - Prudoxin 5 % Topical Cream
- RxCUI: 1000093 - doxepin hydrochloride 50 MG/ML Topical Cream [Prudoxin]
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0378 - Mylan Pharmaceuticals Inc.
- 0378-8130 - Prudoxin
- 0378-8130-45 - 1 TUBE in 1 CARTON / 45 g in 1 TUBE
- 0378-8130 - Prudoxin
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0378-8130-45 identifies a specific commercial package of 1 tube in 1 carton / 45 g in 1 tube of Prudoxin, a human prescription drug labeled by Mylan Pharmaceuticals Inc.. This product is billed per "GM" gram and contains an estimated amount of 45 billable units per package. This cream is formulated for topical use and contains doxepin hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Mylan Pharmaceuticals Inc. on August 01, 2018. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to relieve itching from certain skin conditions (e.g., atopic dermatitis, eczema, neurodermatitis). It should be used only for a short time (no more than 8 days). Doxepin is a tricyclic antidepressant. It is not known how this medication decreases itching. Some medication is absorbed into the body when the cream is applied. This medication may work by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. The decrease in itching may be a result of drowsiness or some other effect in the brain that causes you not to notice or be bothered by the itching.
How is this Mylan Pharmaceuticals Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00378813045. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.